News Archives
June 03, 2013
FERRING PHARMACEUTICALS INC. ANNOUNCES $1M DONATION TO THE ALLIANCE FOR FERTILITY PRESERVATION, A NEWLY FORMED CHARITABLE ORGANIZATIONFERRING PHARMACEUTICALS INC. ANNOUNCES $1M DONATION TO THE ALLIANCE FOR FERTILITY PRESERVATION, A NEWLY FORMED CHARITABLE ORGANIZATION
PARSIPPANY, N.J., June 3, 2013 – Today, Ferring Pharmaceuticals Inc. announced that it will donate...
May 02, 2013
FERRING ANNOUNCES IT WILL PRESENT PHASE 3 DATA FOR CERVICAL RIPENING AGENT AT AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS ANNUAL CLINICAL MEETING
Pivotal data for investigational controlled release misoprostol vaginal insert in the U.S. accepted for...
February 12, 2013
FERRING TO HIGHLIGHT PHASE 3 DATA FOR CERVICAL RIPENING CANDIDATE AT SOCIETY FOR MATERNAL-FETAL MEDICINE ANNUAL MEETING
Pivotal data for investigational controlled release misoprostol vaginal insert in the U.S. accepted for...
October 25, 2012
FERRING ANNOUNCES FDA ACCEPTANCE OF NDA FILING FOR CONTROLLED RELEASE MISOPROSTOL VAGINAL INSERT FOR DECREASING TIME TO VAGINAL DELIVERY IN WOMEN
PARSIPPANY, NJ, October 23, 2012 – Ferring Pharmaceuticals Inc. today announced that the U.S. Food...
September 20, 2012
NJBIZ HONORS NEW JERSEY’S 50 FASTEST GROWING COMPANIES
Ferring Pharmaceuticals Inc. has been named one of New Jersey’s 2012 50 Fastest Growing Companies....
September 10, 2012
DAVE THOMAS FOUNDATION FOR ADOPTION RECOGNIZED BEST ADOPTION-FRIENDLY WORKPLACES IN THE PHARMACEUTICAL INDUSTRY
COLUMBUS, Ohio – Today, the Dave Thomas Foundation for Adoption announced the sixth annual list...
September 06, 2012
WALGREENS JOINS WITH FERRING PHARMACEUTICALS INC. TO OFFER PRODUCTS AND RESOURCES TO WOMEN FACING FERTILITY COMPLICATIONS FROM CANCER TREATMENT
DEERFIELD, Ill. and PARSIPPANY, N.J., Sept. 6, 2012– In honor of National Ovarian Cancer Month...
July 17, 2012
FDA APPROVES FERRING’S PREPOPIK™ (sodium picosulfate, magnesium oxide, and anhydrous citric acid) FOR COLONOSCOPY PREP
New Low-Volume Regimen With 10 Ounces of Prep Solution Parsippany, NJ —July 17, 2012 —The...
July 03, 2012
FERRING PHARMACEUTICALS ACQUIRES LICENSING RIGHTS FOR ELOBIXIBAT FROM ALBIREO AB
Saint-Prex, Switzerland, Gothenburg, Sweden, July 3, 2012 - Ferring Pharmaceuticals (Ferring) and Albireo...
December 09, 2011
EXPERTS LAUNCH THE ALLIANCE FOR FERTILITY PRESERVATION AT THE INTERNATIONAL SOCIETY FOR FERTILITY PRESERVATION'S 2ND WORLD CONGRESS
Miami Beach, FL Dec. 9, 2011 – As hundreds of scientists gathered today to discuss fertility preservation...
November 22, 2011
FERRING PHARMACEUTICALS TO DEVELOP MAJOR CORPORATE CENTER IN PARSIPPANY, NEW JERSEY
Parsippany, NJ —Oct. 21, 2011 — /PRNewswire/ – Switzerland-based Ferring Pharmaceuticals...
October 21, 2011
FDA APPROVES LONGER DURATION EFFICACY AND SAFETY FOR EUFLEXXA®
Parsippany, NJ —Oct. 21, 2011 — On Oct. 11, 2011, the FDA approved a labeling supplement...
October 20, 2011
FERRING ACQUIRES CYTOKINE PHARMASCIENCES INC.
10/20/2011 - Ferring has completed the purchase of Cytokine PharmaSciences Inc. (CPSI) and its UK subsidiary...
October 17, 2011
RETROSPECTIVE ANALYSIS EVALUATES THE EFFECT OF LYSTEDA® ON THE NUMBER OF SLEEP INTERRUPTIONS FOR WOMEN WITH CYCLIC HEAVY MENSTRUAL BLEEDING
Findings presented at Nurse Practitioners in Women’s Health 14th Annual Premier Women’s HealthCare...
May 16, 2011
EXPLORATORY EFFICACY ANALYSIS CONDUCTED FOR LONG-TERM EXTENSION STUDY IN PATIENTS WITH PROSTATE CANCER TREATED WITH FIRMAGON® OR CROSSED OVER TO FIRMAGON FROM LEUPROLIDE
Findings presented at annual urology meeting WASHINGTON, DC – May 16, 2011 – A poster entitled,...
May 06, 2011
FERRING PHARMACEUTICALS TO SUPPORT GREAT PROSTATE CANCER CHALLENGE® EVENTS ACROSS THE COUNTRY IN NATIONAL EFFORT TO END PROSTATE CANCER
Ferring Named Official Sponsor of the Great Prostate Cancer Challenge PARSIPPANY, NJ – May 6,...
May 04, 2011
RETROSPECTIVE ANALYSIS EXPLORES LYSTEDA®’S ABILITY TO REDUCE SLEEP INTERRUPTIONS IN WOMEN WITH CYCLIC HEAVY MENSTRUAL BLEEDING
Findings presented at The American College of Obstetricians and Gynecologists’ 59th Annual Clinical...
April 25, 2011
FERRING CELEBRATES WINNERS OF 2010 MY LITTLE MIRACLE ESSAY CONTEST DURING NATIONAL INFERTILITY AWARENESS WEEK
Contest Brings Hope and Awareness to Millions of Couples Struggling with Infertility PARSIPPANY, NJ...
March 21, 2011
NATIONAL SURVEY OF NURSE PRACTITIONERS REVEALS SERIOUS TOLL OF HEAVY MONTHLY PERIODS
Common Condition Affects Health, Lifestyle and Finances But Patients Delay Reporting Symptoms Washington,...
November 11, 2010
ZERO’S GREAT PROSTATE CANCER CHALLENGE COMES TO CENTRAL FLORIDA TO HELP STOP PROSTATE CANCER IN ITS TRACKS WITH HELP FROM FERRING PHARMACEUTICALS
PARSIPPANY, NJ – November 11, 2010 – Men, women and children from Central Florida have a...
November 01, 2010
ZERO’S DASH FOR DAD AIMS TO STOP PROSTATE CANCER IN ITS TRACKS WITH HELP FROM FERRING PHARMACEUTICALS
PARSIPPANY, NJ – November 1, 2010 – Men, women and children from Long Island and beyond have...
October 26, 2010
ENDOMETRIN VAGINAL INSERTS DEMONSTRATE COMPARABLE EFFICACY TO INTRAMUSCULAR INJECTIONS OF PROGESTERONE-IN-OIL FOR LUTEAL SUPPORT IN GNRH IVF CYCLES
Ferring Pharmaceuticals Presents Study Results at 66th American Society for Reproductive Medicine Annual...
October 06, 2010
OBSTETRICS AND GYNECOLOGY PUBLISHES DATA FROM PIVOTAL PHASE 3 LYSTEDA STUDY
First-ever, FDA-Approved Non-hormonal Treatment Option for Heavy Menstrual Bleeding Parsippany, NJ –...
September 29, 2010
GLORIA GAYNOR TO APPEAR AT AARP’s ORLANDO@50+ NATIONAL EVENT & EXPO
Legendary Singer to Raise Awareness of Knee Osteoarthritis Parsippany, NJ- September 29, 2010 –...
September 29, 2010
EUFLEXXA® TO BE PRESENTING SPONSOR OF THE 2010 NATIONAL SENIOR GAMES CHAMPIONSHIPS AND EUFLEXXA HOCKEY CLASSIC
PARSIPPANY, NJ – September 29, 2010 – Ferring Pharmaceuticals Inc. has announced that EUFLEXXA...
September 27, 2010
“THE QUEEN OF DISCO” GLORIA GAYNOR TO PERFORM AT HUNTSMAN WORLD SENIOR GAMES
Legendary Singer to Raise Awareness of Knee Osteoarthritis Parsippany, NJ – September 23, 2010...
September 14, 2010
LANDMARK NATIONAL SURVEY CONDUCTED BY HARRIS INTERACTIVE® SHEDS LIGHT ON HIDDEN PROBLEM OF HEAVY MONTHLY PERIODS
Condition Negatively Affects Women’s Social Life, Physical Activities, Relationships, and Daily...
August 19, 2010
NEW PILL FOR WOMEN WITH HEAVY PERIODS
WAVY.com - Norfolk VA
August 18, 2010
DRUG OFFERING MONTHLY RELIEF TO WOMEN
WTVD-TV Durham, NC
August 16, 2010
FERRING PHARMACEUTICALS’ FIRMAGON® JOINS RACE TO END PROSTATE CANCER AS OFFICIAL SPONSOR OF THE GREAT PROSTATE CANCER CHALLENGE / DASH FOR DAD
Ferring to Support Thousands of Runners and Walkers Throughout the US PARSIPPANY, NJ – August...
July 12, 2010
FERRING PHARMACEUTICALS’ FIRMAGON® NAMED OFFICIAL SPONSOR OF ED RANDALL’S BAT FOR THE CURE
Partnership To Help “Strike-Out Prostate Cancer” Through Awareness, Early Detection and Effective...
June 21, 2010
Ferring Pharmaceuticals Announces Immediate Availability Of Lysteda™, The First Non-Hormonal Therapy Indicated Specifically For Cyclic Heavy Menstrual Bleeding
Information for Patients and Physicians Available at www.lysteda.com Parsippany, NJ – June 21,...
June 01, 2010
Extension study with FIRMAGON® (degarelix) showed continued benefits for prostate cancer patients beyond one year
ANNOUNCED AT LEADING UROLOGY MEETING San Francisco, CA – June 1, 2010 – Prostate cancer...
June 01, 2010
FIRMAGON® RESULTS IN FAST, LONG-TERM SUPPRESSION OF TESTOSTERONE IN PROSTATE CANCER PATIENTS WITHOUT INITIAL TESTOSTERONE SURGE
Symposia Presented Innovative Approach to Treatment at Leading Urology Meeting SAN FRANCISCO –...
May 19, 2010
CLINICAL DATA DEMONSTRATES THAT LYSTEDA™ SIGNIFICANTLY REDUCED MENSTRUAL BLOOD LOSS AND LIMITATIONS ON SOCIAL, LEISURE AND PHYSICAL ACTIVITIES IN WOMEN WITH CYCLIC HMB
Ferring presents findings at The American College of Obstetricians and Gynecologists 58th Annual Clinical...
May 17, 2010
GLORIA GAYNOR TO PERFORM AT JACKSONVILLE’S SENIOR EXPO AND HEALTH FAIR
Legendary Singer Hopes to Raise Awareness of Knee Osteoarthritis Parsippany, NJ – Grammy Award...
May 12, 2010
FERRING PHARMACEUTICALS ANNOUNCES DISCO ICON GLORIA GAYNOR AS NATIONAL SPOKESPERSON FOR EUFLEXXA®
Parsippany, NJ – Ferring Pharmaceuticals Inc. announces that Grammy Award winner Gloria Gaynor...
May 10, 2010
FERRING ACQUIRES LYSTEDA™ FROM XANODYNE PHARMACEUTICALS, INC.
Global Acquisition Expands Ferring’s Role in Women’s Health SAINT-PREX, Switzerland –...
April 01, 2010
XANODYNE AND FERRING ANNOUNCE CO-PROMOTE FOR ZIPSOR™
NEWPORT, Ky. and PARSIPPANY, N.J., April 1 /PRNewswire/ – Xanodyne Pharmaceuticals, Inc., an integrated...
March 08, 2010
NEW ARTICLE REVEALS TREND TOWARD GREATER USE OF HUMAN MENOPAUSAL GONADOTROPIN IN IN VITRO FERTILIZATION
Review Article of hMG Published in US Obstetrics & Gynecology PARSIPPANY, NJ – March 8, 2010...
March 01, 2010
WIN A $10,000 EDUCATION FUND FOR YOUR MIRACLE CHILD
Ferring Pharmaceuticals Announces 2010 My Little Miracle Essay Contest PARSIPPANY, NJ – March...
February 25, 2010
FERRING PHARMACEUTICALS AND GENE SECURITY NETWORK PARTNER TO TEST ADVANCED PREIMPLANTATION GENETIC DIAGNOSIS (PGD) TECHNOLOGY
Eleven-Center Trial to Evaluate Technology for Superior Accuracy in IVF Embryo Selection PARSIPPANY,...
December 04, 2009
DEGARELIX (FIRMAGON®) VS LEUPROLIDE (LUPRON DEPOT®) IN PATIENTS WITH ADVANCED PROSTATE CANCER: FURTHER ANALYSIS FROM A PHASE III PIVOTAL TRIAL
Investigators Presented Results at the Society of Urologic Oncology Annual Meeting BETHESDA, MD –...
October 20, 2009
RESEARCH COMPARES MENOPUR® WITH rFSH IN GNRH ANTAGONIST IVF CYCLES
Ferring Pharmaceuticals Presents Study Results at American Society for Reproductive Medicine Annual Meeting ATLANTA...
August 31, 2009
RECENTLY PUBLISHED STUDY DEMONSTRATES PHARMACOKINETIC ADVANTAGES OF ENDOMETRIN® OVER CRINONE® FOR PROGESTERONE SUPPLEMENTATION
Study Published Online in Fertility & Sterility PARSIPPANY, NJ – August 31, 2009 – ENDOMETRIN®...
August 04, 2009
FERRING PHARMACEUTICALS ANNOUNCES TRADE NAME FIRMAGON® (degarelix for injection) FOR ADVANCED PROSTATE CANCER TREATMENT
PARSIPPANY, NJ – August 4, 2009 – Ferring Pharmaceuticals announced today that the U.S. Food...
May 13, 2009
FERRING PHARMACEUTICALS UNVEILS SIX-MONTH EFFICACY DATA FOR EUFLEXXA® FOR THE TREATMENT OF OSTEOARTHRITIS KNEE PAIN
Results Show Superior Decrease in Pain Scores Compared to Saline PARSIPPANY, NJ – May 13, 2009...
April 27, 2009
FERRING PHARMACEUTICALS LAUNCHES PHASE IIIB TRIAL OF DEGARELIX AS INTERMITTENT THERAPY
Trial Will Build on Pivotal Phase III Study for the Treatment of Advanced Prostate Cancer PARSIPPANY,...
April 27, 2009
FERRING PHARMACEUTICALS AND RESOLVE: THE NATIONAL INFERTILITY ASSOCIATION JOIN TOGETHER TO LAUNCH NURSE LIAISON PROGRAM
Program to Launch During RESOLVE’s National Infertility Awareness Week®, April 25 - May 2 Across...
April 13, 2009
NEW APPROACH TO PROGESTERONE SUPPLEMENTATION IN ART REVEALED IN RECENTLY PUBLISHED WHITE PAPER
Expert Panel: Vaginal Progesterone Preferred for Luteal Support in ART PARSIPPANY, NJ – April...
March 24, 2009
THRIVING FERRING TO OPEN NEW SITE -
PHARMACEUTICAL IS EXPANDING LOCALLY
San Diego Union-Tribune
February 10, 2009
March 24, 2009
FERRING SUPPORTS A ROUNDTABLE DISCUSSION ABOUT COLLABORATIVE INFERTILITY CARE BETWEEN REPRODUCTIVE ENDOCRINOLOGISTS AND OBGYNS
March 03, 2009
FERRING PHARMACEUTICALS ANNOUNCES IMMEDIATE AVAILABILITY OF DEGARELIX FOR THE TREATMENT OF ADVANCED PROSTATE CANCER
New Drug Provides Rapid and Sustained Suppression of Testosterone PARSIPPANY, NJ – March 4, 2009...
February 17, 2009
FERRING PHARMACEUTICALS ANNOUNCES THREE STUDENT WINNERS OF TERRY MCMORROW SCHOLARSHIPS
Parsippany, NJ – February 17, 2009 – Ferring Pharmaceuticals has announced the three local...
December 24, 2008
FDA APPROVES FERRING PHARMACEUTICALS' DEGARELIX (generic name) FOR TREATMENT OF ADVANCED PROSTATE CANCER
FOR IMMEDIATE RELEASE CONTACT: Tara Fisher Kovak-Likly Communications 203-762-8833, tfisher@klcpr.com...
April 09, 2008
WIN A $10,000 EDUCATION FUND FOR YOUR MIRACLE CHILD
Contact: Christine Stroup FOR IMMEDIATE RELEASE Kovak-Likly Communications (203) 762-8833 or CStroup@KLCpr.com...
April 18, 2007
FERRING REPORTS ON ENDOMETRIN® PRESENTATIONS AT PACIFIC COAST REPRODUCTIVE SOCIETY ANNUAL MEETING
CONTACT: Andrea Preston FOR IMMEDIATE RELEASE Kovak-Likly Communications 203-762-8833, apreston@klcpr.com...
June 07, 2006
COMPARATIVE STUDY SHOWS SAFER, MORE CONTROLLED STIMULATION WITH MENOPUR® THAN GONAL-f® IN OVULATION INDUCTION
CONTACT: Marilyn Seiger FOR IMMEDIATE RELEASE Kovak-Likly Communications 203-762-8833, mseiger@klcpr.com...
May 30, 2006
NATIONWIDE SURVEY FINDS ONLY 30 PERCENT OF PATIENTS UNDERGOING INFERTILITY TREATMENT ARE ABLE TO ADMINISTER THEIR MEDICATIONS WITH ONE INJECTION PER DAY
CONTACT: Andrea Preston FOR IMMEDIATE RELEASE Kovak-Likly Communications 203-762-8833, apreston@klcpr.com...
April 10, 2006
FERRING PHARMACEUTICALS ANNOUNCES EUFLEXXA™ LABELING EXTENDED TO INCLUDE ROOM TEMPERATURE STORAGE
CONTACT: Tara Fisher FOR IMMEDIATE RELEASE Kovak-Likly Communications 203-762-8833, tfisher@klcpr.com...
February 27, 2006
WIN A $10,000 EDUCATION FUND FOR YOUR MIRACLE CHILD
CONTACT: Christine Stroup FOR IMMEDIATE RELEASE Kovak-Likly Communications (203) 762-8833 or CStroup@KLCpr.com...
February 14, 2006
HEAD-TO-HEAD STUDY SHOWS EUFLEXXA™ HAS GREATER TOLERABILITY COMPARED TO SYNVISC® FOR OSTEOARTHRITIS KNEE PAIN
CONTACT: Tara Fisher FOR IMMEDIATE RELEASE Kovak-Likly Communications 203-762-8833, tfisher@klcpr.com...
February 14, 2006
FERRING PHARMACEUTICALS ANNOUNCES BRUCE JENNER AS NATIONAL SPOKESPERSON FOR EUFLEXXA™
CONTACT: Tara Fisher FOR IMMEDIATE RELEASE Kovak-Likly Communications 203-762-8833, tfisher@KLCpr.com...
November 14, 2005
FERRING PHARMACEUTICALS ANNOUNCES LAUNCH OF EUFLEXXA™ FOR OSTEOARTHRITIS KNEE PAIN
Contact: Kelly Laban FOR IMMEDIATE RELEASE Kovak-Likly Communications (203) 762-8833 x15 or KLaban@KLCpr.com...
July 19, 2005
FERRING PHARMACEUTICALS OBTAINS RIGHTS TO EUFLEXXA™
Enters Co-Promotion Agreement with Savient Contact: Kelly Laban Kovak-Likly...
May 20, 2005
WIN A $10,000 EDUCATION FUND FOR YOUR MIRACLE CHILD
Ferring Pharmaceuticals Announces 2005 My Little Miracle Essay Contest Contact: ...
May 11, 2005
FERRING PHARMACEUTICALS APPOINTS WILLIAM GARBARINI AS SENIOR DIRECTOR OF MARKETING
Responsible for Marketing for Newly Created Orthopedics/Urology Business Unit Contact: ...
May 11, 2005
FERRING PHARMACEUTICALS APPOINTS OLIVIER DELANNOY AS VICE PRESIDENT, INFERTILITY BUSINESS UNIT
Contact: Kelly Laban Kovak-Likly Communications (203)762-8833 x15 or...
April 11, 2005
FERRING PHARMACEUTICALS ANNOUNCES LAUNCH OF NEW TREATMENT FOR INFERTILITY
MENOPUR® (menotropins for injection, USP) First Gonadotropin to Receive FDA Approval Based on Pregnancy...
January 11, 2005
MICHAEL SECKLER APPOINTED NATIONAL SALES DIRECTOR FOR FERRING PHARMACEUTICALS
Contact: Kelly Laban Kovak-Likly Communications (203)762-8833 x15 or...
December 10, 2004
LOCAL WOMAN WINS $1,000 FOR HER 19-MONTH-OLD SON
Monroe Resident Wins Honorable Mention Prize for Ferring’s My Little Miracle Essay Contest ...
December 10, 2004
GEORGIA REPRODUCTIVE SPECIALISTS CELEBRATES WITH ITS PATIENT NAMED AS WINNER OF FERRING'S MY LITTLE MIRACLE ESSAY CONTEST
Ferring Presents $1,000 to Local Honorable Mention Winner Contact: Kelly Laban ...
December 10, 2004
LOCAL MAN WINS $5,000 FOR HIS 11-MONTH-OLD CHILDREN
Northville Resident Wins Runner-Up Prize in Ferring’s My Little Miracle Essay Contest ...
December 10, 2004
OAK BROOK FERTILITY CELEBRATES WITH ITS PATIENT NAMED AS WINNER OF FERRING'S MY LITTLE MIRACLE ESSAY CONTEST
Ferring Presents $1,000 to Local Honorable Mention Winner Contact: Kelly Laban ...
December 10, 2004
FAMILY BEGINNINGS CELEBRATES WITH ITS PATIENTS NAMED AS WINNERS OF FERRING'S MY LITTLE MIRACLE ESSAY CONTEST
Ferring Presents $3,000 in Prizes to Honorable Mention Winners Contact: Kelly...
December 08, 2004
LOCAL FERTILITY PRACTICE CELEBRATES PATIENT NAMED AS WINNER OF FERRING'S MY LITTLE MIRACLE ESSAY CONTEST
Ferring Presents $1,000 to Honorable Mention Winner Contact: Kelly Laban Kovak-Likly...
October 18, 2004
FERRING PRESENTS $10,000 GRAND PRIZE TO WINNER OF MY LITTLE MIRACLE ESSAY CONTEST
Contest Winner Announced at ASRM Contact: Kelly Laban Kovak-Likly Communications ...
October 18, 2004
SOCIETY FOR REPRODUCTIVE ENDOCRINOLOGY AND INFERTILITY ANNOUNCES FERRING PHARMACEUTICALS' SPONSORSHIP OF FELLOWS' RETREAT 2005-2007
Contact: Kelly Laban Kovak-Likly Communications (203)762-8833 or KLaban@KLCpr.com ...
October 18, 2004
FERRING INTRODUCES BRAVELLE® WITH FIRST NEEDLE-FREE RECONSTITUTION DEVICE
Q·Cap™ Previewed at Annual ASRM Meeting Contact: Kelly Laban ...
October 18, 2004
FERRING SUPPORTS SYMPOSIUM ON OPTIMIZING ASSISTED REPRODUCTIVE TECHNOLOGY (ART)
Held at 60th Annual Meeting of the American Society for Reproductive Medicine Contact: ...
July 21, 2004
WIN A $10,000 EDUCATION FUND FOR YOUR MIRACLE CHILD
Ferring Pharmaceuticals Announces My Little Miracle Essay Contest Contact:Kelly LabanKovak-Likly Communications(203)762-8833...
April 28, 2004
RESULTS OF EMBRACE* TRIALS PRESENTED AT THE PACIFIC COAST REPRODUCTIVE SOCIETY MEETING
First-Ever Systematic Evaluation of Mixed Protocols in IVF Contact: Marilyn Seiger Kovak-Likly...
February 10, 2003
CLINICAL STUDY CONFIRMS EFFECTIVENESS OF FERRING'S NEW BRAVELLE® IN PRODUCING DONOR EGGS FOR IVF
Study appears in Today’s Therapeutic Trends Contact: Marilyn Seiger Kovak-Likly...
December 19, 2002
FDA APPROVES BRAVELLE™ FOR IN VITRO FERTILIZATION
Clinical Trial Demonstrates State-of-the-Art Performance With Significantly Less Injection Site Pain...
November 11, 2002
THE AMERICAN INFERTILITY ASSOCIATION, RESOLVE AND FERRING TEAM UP TO IMPROVE ACCESS TO INFERTILITY TREATMENT
Contact: Kelly Laban Kovak-Likly Communications 203.762.8833 or Klaban@KLCpr.com TARRYTOWN, NY –...
June 10, 2002
CLINICAL STUDY SUPPORTS IVF INDICATION FOR FERRING'S NEW BRAVELLE™ (urofollitropin for injection, purified)
Study appears in June issue of Fertility and Sterility TARRYTOWN, NY – June 10, 2002 – According...
May 06, 2002
FDA APPROVES BRAVELLE™ (urofollitropin for injection, purified) FERRING\’S NEW HUMAN-DERIVED FOLLICLE-STIMULATING HORMONE FOR INFERTILITY TREATMENT
New Highly Purified Alternative To Genetically Engineered Infertility Treatments CONTACT: Marilyn...
April 29, 2002
FERRING PHARMACEUTICALS PRESENTS DATA ON NEW INFERTILITY TREATMENTS AT THE PACIFIC COAST REPRODUCTIVE SOCIETY MEETING
CONTACT: Marilyn Seiger Kovak-Likly Communications 203-762-8833 Rancho Las Palmas, CA –...
October 24, 2001
FERRING PHARMACEUTICALS HONORED BY THE AMERICAN INFERTILITY ASSOCIATION
CONTACT: Marilyn Seiger Kovak-Likly Communications 203-762-8833 NEW YORK - October 24, 2001 –...
October 24, 2001
FERRING PHARMACEUTICALS LAUNCHES NEW WEB SITE OFFERING INFORMATION ON INFERTILITY TREATMENT
Web site launched at 57th Annual American Society for Reproductive Medicine (ASRM) Meeting in Orlando Contact:...
February 28, 2001
FERRING INITIATES LANDMARK CLINICAL TRIALS TO EVALUATE OPTIMAL DRUG PROTOCOL FOR IVF TREATMENT
FOR IMMEDIATE RELEASE CONTACT: Marilyn Seiger Kovak-Likly Communications 203/762-8833 First-ever Evaluation...
The Ferring USA Product Line
 |
 |
 |
 |
 |